Skip to main content
ELVN logo

ELVN

Enliven Therapeutics, Inc.

$53.16

2.76%

Trade Ideas Performance

Latest Closed Trade Idea

$53.16

2.76%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

0

Social

12

About

Events of Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics' stock price has been influenced by positive clinical data from ELVN-001, strong financial reporting, presentations at healthcare conferences, and industry validation such as Merck's acquisition of Terns Pharmaceuticals. Conversely, reports of insider selling, a proposal to double authorized shares, and a director's proposed insider sale have negatively impacted the stock.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Enliven Therapeutics, Inc. (ELVN) Live Stock Price, Chart & Financial News | Edge Hound